PSCA应用的新进展:前列腺癌的诊断,治疗和判断预后
摘要
近几年来,随着对前列腺干细胞抗原(PSCA)研究的不断深入PSCA的应用,特别是在诊断、治疗和判断预后方面有了长足的进展。本文主要对PSCA最近在前列腺癌诊断、治疗和预后判断方面,特别是PSCA用于PET影像学诊断和最新免疫治疗方面的研究进展做一总结。
出处
《现代泌尿外科杂志》
CAS
2012年第1期103-105,108,共4页
Journal of Modern Urology
参考文献18
-
1REITER RE,GUZ,WATABE T,et al. Prostate stem cell antigen: a cell surface maker overexpressed in prostate cancer[J]. Natl Acad SciUSA, 1998,95(4):1735-1740.
-
2ANTICA M,WUL,SCOLLAY R. Stem cell antigen 2 expression in adult and developing mice[J]. Immunol Lett, 1997,55(1):47-51.
-
3REGE T, HAGOOD J. Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses[J]. Biochim Biophys Acta, 2006, 1763(10):991-999.
-
4MOOREML, TEITELLMA, YOON KIM, et al. Deletion of PSCA increases metastasis of tramp-induced prostate tumors without altering primary tumor formation[J].The Prostate,2008,68(2):139-151.
-
5ZHIGANG Z, WENLU S. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer[J].Jpn J Clin Oncol,2006,36(2):121.
-
6TOVE OLAFSEN, GU Z, SHERMAN MA,et al. Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (psca) antibody[J].J Immunother,2007, 30(4):396-405.
-
7JEFFERY JV, OLAFSEN T, LEPIN EJ, et al. Humanized radioiodinated minibody for imaging of prostate stem cell antigen^ expressing tumors[J].Clin. Cancer Res, 2008,14(22):7488-7496.
-
8LEPIN EJ, LEYTON JV, ZHOU Y, et al. An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors[J].Eur J Nucl Med Mol Imaging, 2010,37(8): 1529-1538.
-
9ZHANG X, YU C, ZHAO J, et al. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice [J].J Gene Med,2007,9(8):715-726.
-
10PETRIGLIANO FA, VIRK MS, LIU N,et al. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (psca) promoter[J]. Prostate, 2009, 69(13):1422-1434.
-
1马宏武,贾豫东,王安奇,程传宇.前列腺干细胞抗原在前列腺癌中的表达及与血清PSA的关系[J].医药论坛杂志,2010,31(13):59-60. 被引量：1
-
2陈海昕,李汉忠.前列腺干细胞抗原(PSCA)在前列腺癌研究中的新进展[J].国外医学（泌尿系统分册）,2004,24(2):184-188.
-
3周家鹏,周建平,舒国顺,袁联文,任峰,刘栋才,杨竹林.直肠腺癌PSCA,OCT-4,CD24和CD44v6表达及其临床意义[J].中国普通外科杂志,2010,19(7):774-778. 被引量：5
-
4董尧(综述),陈家存(审校).前列腺干细胞抗原与膀胱肿瘤[J].国际泌尿系统杂志,2008,28(5):632-635.
-
5解昆,余闫宏,肖民辉.膀胱癌相关易感基因PSCA的研究现状[J].重庆医学,2013,42(26):3178-3180. 被引量：2
-
6陶伟,单玉喜,李玲玲,王文熲.不同组织中前列腺干细胞抗原的表达分析[J].苏州大学学报（医学版）,2004,24(5):684-685.
-
7马益如,潘国英.鼻咽癌的诊断,治疗和病因[J].实用肿瘤杂志,1990,5(1):1-14. 被引量：2
-
8韩刚,于继云,高江平.以PSCA为靶点的前列腺癌免疫治疗的研究进展[J].军医进修学院学报,2009,30(2):225-226. 被引量：1
-
9汪良,曾甫清.前列腺干细胞抗原和前列腺癌[J].临床泌尿外科杂志,2003,18(1):52-54.
-
10刘蓉,路名芝,谢绮.前列腺癌中PSMA、PSCA的表达与病理分级、骨转移和预后的关系及其临床意义[J].实用临床医学（江西）,2012,13(2):136-138. 被引量：6
